Adjunctive Therapies for Management of Type 1 Diabetes, An Issue of Endocrinology and Metabolism Clinics of North America

In this issue of Endocrinology and Metabolism Clinics, guest editors Drs. Viral N. Shah and Courtney Ackeifi bring their considerable expertise to the topic of Adjunctive Therapies in Type 1 Diabetes. Top experts discuss the latest developments in adjunctive therapies to improve glycemic control, reduce complications, and enhance quality of life for individuals with type 1 diabetes. By targeting mechanisms beyond insulin deficiency—such as insulin resistance, appetite regulation, and renal protection—adjunctive therapies hold promise for delaying disease progression, reducing insulin requirements, and minimizing adverse effects associated with intensive insulin therapy.